At 20mg/mL, doses from 2mg to 12mg all fit in one draw, making it the most versatile concentration for a full dose escalation schedule
Combining with DPP-4 inhibitors is generally not recommended, as both drug classes work on the incretin system Adding basal insulin for those with more significant hyperglycaemia, which can be used alongside GLP-1 medications (with careful monitoring for hypoglycaemia) Switching to insulin therapy entirely may be necessary for those with advanced beta cell failure For weight management , when GLP-1 medications don't produce adequate weight loss, alternatives include: Orlistat , a lipase inhibitor that reduces fat absorption, though weight loss is typically modest (2-3 kg on average) Naltrexone-bupropion (Mysimba), which works on appetite centres through different pathways
Read about how we use cookies.
Diabetes and Blood Sugar Research The combined GLP-1, GIP, and glucagon action of retatrutide peptide offers researchers a powerful tool for studying glucose homeostasis and diabetes care strategies
The additives do not change optimal injection sites
Request comprehensive metabolic panels every three to six months during treatment and every one to three months during and after tapering